Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Beverley V. Adams"'
Autor:
Charles Y.C. Pak, Ming‐Chue ‐C Hsu, Carol Parcel, Faye Britton, Joseph E. Zerwekh, Beverley V. Adams, Christopher Gallagher, Martha Lemke, Khashayar Sakhaee, Roy D. Peterson
Publikováno v:
Journal of Bone and Mineral Research. 1:563-571
The bioavailability, biochemical effects, and safety of a slow-release preparation of sodium fluoride were examined. In 8 normal volunteers, a single administration of slow-release sodium fluoride (25 mg) caused a slow rise and gradual decline in ser
Autor:
Khashayar Sakhaee, Abdillahi Bahar, Charles Y.C. Pak, Carol Parcel, Robert Beckley, Beverley V. Adams, John R. Poindexter
Publikováno v:
Journal of Bone and Mineral Research. 5:857-862
Clinical pharmacology of slow-release sodium fluoride given with calcium citrate was examined in acute and long-term studies. Following a single oral administration of 50 mg slow-release sodium fluoride, a peak serum fluoride concentration (Cmax) of
Publikováno v:
The Journal of clinical endocrinology and metabolism. 75(6)
Ketoconazole was used to probe the pathogenetic importance of the serum 1,25-dihydroxyvitamin D [1,25-(OH)2D] concentration in 19 patients with well characterized absorptive hypercalciuria (AH). Patients were studied while receiving a constant metabo
Autor:
William B. Campbell, James M. Schmitz, Beverley V. Adams, Harold D. Itskovitz, Celso E. Gomez-Sanchez
Publikováno v:
Journal of Clinical Investigation. 64:1552-1557
The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspension
Publikováno v:
Journal of Urology. 136:1003-1008
The effect of long-term treatment with alpha-mercaptopropionylglycine was examined in 66 patients with cystinuria. Of the patients 49 took D-penicillamine before therapy, whereas 17 did not. Over-all side effects to alpha-mercaptopropionylglycine wer
Autor:
Charles Y.C. Pak, Beverley V. Adams
Publikováno v:
Renal Stone Disease ISBN: 9781461292289
Potassium citrate is a new and exciting therapeutic modality introduced in 1985 for the management of a wide variety of stone-forming disorders. It has reawakened interest in the deranged citrate metabolism in nephrolithiasis and in the physicochemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6229b9ac734377ec139f3636951367ad
https://doi.org/10.1007/978-1-4613-2069-2_8
https://doi.org/10.1007/978-1-4613-2069-2_8